Teriflunomide Tablet, Film Coated
Product Images NDC 0480-3157

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 0480-3157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of Teriflunomide, showing its molecular components including a trifluoromethyl-substituted benzene ring and an unsaturated amide group with a nitrile and hydroxyl functional groups.*

FDA Label Image

1 (Image 2)

A line graph showing disability progression sustained for 12 weeks over a period of 108 weeks comparing placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide. The y-axis represents the percentage of disability progression, while the x-axis represents time in weeks. The graph includes a number at risk table at the bottom for each treatment group at various weeks. A statistical note indicates a significant difference between 14 mg Teriflunomide and placebo (p < 0.05).*

FDA Label Image

1 (Image 3)

A line graph comparing disability progression sustained for 12 weeks (%) over time (weeks) between placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The graph includes a table showing the number of subjects at risk at various time points for each group. A significant difference (p < 0.05) is noted between 14 mg Teriflunomide and placebo at the end of the study period.*

FDA Label Image

1 (Image 4)

Label for Teriflunomide Tablets 7 mg, a human prescription drug in film-coated tablet form, manufactured by Teva Pharmaceuticals, Inc. The label indicates a package quantity of 30 tablets and includes a NDC code 0480-3157-56. It features instructions for the pharmacist to dispense the accompanying Medication Guide to each patient and includes storage and usage information as well as a barcode.*

FDA Label Image

1 (Image 5)

Label for Teriflunomide Tablets 14 mg from Teva Pharmaceuticals, Inc. The label includes the NDC code 0480-3156-56, states prescription use only, and provides directions for daily oral administration. It lists storage conditions, manufacturing information from Teva Pharmaceuticals Ltd. in Israel, and a package size of 30 film-coated tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.